AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023
23 Febbraio 2023 - 10:05PM
Business Wire
AbCellera (Nasdaq: ABCL) today announced that it will present at
the Cowen 43rd Annual Health Care Conference on Monday, March 6,
2023, at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
A live audio webcast of the presentation may be accessed through
a link that will be posted on AbCellera's Investor Relations
website. A replay will be available through the same link following
the presentation.
About AbCellera Biologics Inc.
AbCellera searches, decodes, and analyzes natural immune systems
to find antibodies that its partners can develop into drugs to
prevent and treat disease. AbCellera partners with drug developers
of all sizes, from large pharmaceutical to small biotechnology
companies, empowering them to move quickly, reduce costs, and
tackle the toughest problems in drug development. For more
information, please visit www.abcellera.com.
Source: AbCellera Biologics Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230222006058/en/
Inquiries Media: Jessica Yingling, Ph.D.;
media@abcellera.com, +1(236)521-6774 Business Development: Murray
McCutcheon, Ph.D.; bd@abcellera.com, +1(604)559-9005 Investor
Relations: Josephine Hellschlienger, Ph.D.; ir@abcellera.com,
+1(778)729-9116
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Giu 2024 a Lug 2024
Grafico Azioni AbCellera Biologics (NASDAQ:ABCL)
Storico
Da Lug 2023 a Lug 2024